查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1233129

2023-2030 年按技术（NGS、其他）按工作流程按应用按类型按最终用途按地区按细分趋势分列的靶向测序和重测序市场规模、份额和趋势分析报告

Targeted Sequencing And Resequencing Market Size, Share & Trends Analysis Report By Technology (NGS, Others), By Workflow, By Application, By Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

靶向测序和重测序市场增长和趋势

Grand View Research, Inc. 的新报告显示，全球靶向测序和重测序市场规模从 2023 年到 2030 年将以 22.59% 的复合年增长率增长，预计将达到 257 亿美元

基因组测序仪的持续技术发展以及 NGS 技术的广泛应用和采用预计将推动市场增长。 此外，预计 NGS 在分子诊断和精准医学中的应用扩大也将为市场增长创造机会。

NGS 连同无创产前检测、移植医学和药物基因组学，预计将越来越多地被用于治疗各种疾病和传染病。 靶向基因组和通过 qPCR 进行的基因表达谱分析是 NGS 测序在病理实验室中最常见的两个应用。 虽然肿瘤学仍然是临床使用 NGS 的主要领域，但病理学家有望在未来几年在其他领域采用 NGS。 预计这些因素将在预测期内推动市场增长。

另一方面，新产品的推出有望推动靶向测序和重测序市场的增长。 例如，2022 年 10 月，Illumina 基因组学论坛宣布推出 NovaSeq X，该系统每年能够在一个系统中运行大约 20,000 个全基因组。 这个新系统有 100 亿个流通池。 使用 2x150 碱基对读取时输出 6TB。 此外，2021 年 12 月，F. Hoffmann-La Roche AG 宣布推出 AVENIO Edge System，以简化 NGS 样品製备的自动化并推进精准医学。 这个新颖的系统是一个端到端的集成预分析平台，可提供始终如一的高质量结果。

靶向测序和重测序市场的主要参与者正在专注于合作以巩固其市场地位。 例如，2021 年 3 月，Illumina 与 Genseeq 合作，在中国商业化和开髮用于癌症治疗的 IVD NGS 试剂盒。 该新型试剂盒是使用 Illumina 的 NextSeq 550Dx 测序系统开发的，并已获得中国 NMPA（国家药品监督管理局）的批准。 此外，2021 年 3 月，Hackensack Meridian Health 和基因组检测合作社 (GTC) 建立了合作伙伴关係，在美国建立了一个肿瘤学特异性 RNA 和 DNA 测序实验室。 该实验室（Anthology Diagnostics）将对液体活检样本中的游离 DNA 和肿瘤样本中的 DNA/RNA 进行 NGS。

靶向测序和重测序市场报告亮点

  • 整体靶向测序和重测序市场的增长归功于 NGS 在疾病诊断、药物开发和研究应用等各种应用中的日益普及。
  • 在测序技术方□□面，由于基因组测序在人类基因研究、微生物研究、癌症研究等领域的应用越来越广泛，因此测序领域在市场上占据主导地位。
  • 2022年，临床应用领域将占据很大份额。 靶向测序广泛应用于患者分层和靶向治疗药物开发的临床研究和试验中。
  • 药物开发领域预计在未来几年会占据很大的市场份额。 NGS 技术可以开发药物开发过程所需的多个级别的基因组数据，从基因改变到转录组量化和分析再到表观遗传修饰。
  • 在最终用途方面，预计医院和诊所在预测期内将占据很大的市场份额。 这是由于临床医生越来越多地使用 NGS 来测试多个基因的突变、拷贝数改变和融合。
  • 北美在 2022 年主导了靶向测序和重测序市场，这归功于主要参与者的存在以及政府为增加 NGS 技术的采用而做出的有利努力。

内容

第一章调查方法及范围

  • 信息采购
  • 信息或数据分析
  • 市场范围和细分定义
  • 市场模型
    • 市场调查，按公司市场份额
    • 区域分析

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章市场变量、趋势和范围

  • 市场细分和范围
  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场前景
  • 市场趋势和前景
  • 市场动态
    • 与采用靶向测序方法和降低测序成本相关的成本降低优势
    • 与靶向基因组合和扩增子测序相关的优势
    • 测序技术和相关辅助协议方面的技术进步
    • 在更短的时间内完成测序的进步
    • 数字化二代测序技术简介
    • 基于靶向测序的研究项目有所增加，随之而来的是基因组医学的普及
  • 市场製约因素分析
    • 新兴国家在处理和管理测序技术方□□面面临的挑战
    • 与设置和维护测序设施相关的高成本
    • 缺乏熟练和训练有素的人员
    • 使用基因组数据操作和分析工具的机会有限
  • 2022 年渗透率和增长前景图
  • 商业环境分析
    • SWOT 分析；按因素（政治和法律、经济和技术）
    • 波特的五力分析
  • COVID-19 影响分析

第 4 章技术业务分析

  • 靶向测序和重测序市场：技术波动分析
  • 测序
  • 重新排序
      • 基于电泳的测序
      • 下一代测序
      • 基于阵列的测序

第五章应用业务分析

  • 靶向测序和重测序市场：应用差异分析
  • 临床应用
  • 动植物科学
  • 药物开发

第6章类型业务分析

  • 靶向测序和重测序市场：类型变异分析
  • 基于 DNA 的靶向测序
  • 基于 RNA 的靶向测序

第 7 章最终用途业务分析

  • 靶向测序和再测序市场：最终用途变异分析
  • 医院和诊所
  • 学术研究
  • 其他

第八章区域业务分析

  • 2022 年和 2030 年各地区的靶向测序和重测序市场份额
  • 北美
    • SWOT 分析
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 欧洲
    • SWOT 分析
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 亚太地区
    • SWOT 分析
    • 日本
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 中国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 印度
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 韩国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 澳大利亚
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 泰国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 拉丁美洲
    • SWOT 分析
    • 巴西
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 墨西哥
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿根廷
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 多边环境协定
    • SWOT 分析
    • 南非
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 沙特阿拉伯
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 科威特
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景

第9章竞争格局

  • Participant's overview
  • Financial performance
  • Participant categorization
    • 市场领导者
    • 2022 年靶向测序和重测序市场份额分析
    • 公司简介
      • Illumina, Inc.
      • F. Hoffmann-La Roche Ltd
      • Agilent Technologies
      • GATC Biotech Ag
      • Oxford Nanopore Technologies
      • Thermo Fisher Scientific, Inc.
      • DNASTAR Inc.
      • QIAGEN
      • BGI
      • Perkin Elmer, Inc.
      • PacBio
      • Bio-Rad Laboratories, Inc.
      • Integrated DNA Technologies, Inc.
      • RainDance Technologies, Inc.
      • PierianDx
      • Genomatix GmbH
      • Macrogen, Inc.
    • 战略规划
      • 分机
      • 得到
      • 协作
      • 推出产品/服务
      • 伙伴关係
      • 其他
Product Code: GVR-4-68040-031-6

Targeted Sequencing And Resequencing Market Growth & Trends:

The global targeted sequencing and resequencing market size is expected to reach USD 25.7 billion expanding at a CAGR of 22.59% from 2023 to 2030, according to a new report by Grand View Research, Inc. Owing to the continuous technological developments in genome sequencers along with broad applications and adoption of NGS technology is expected drive the market growth. Furthermore, the increasing application of NGS in molecular diagnostics and precision medicione is also anticipated to create growth opportunities for market growth.

NGS is expected to witness increasing adoption in various disease conditions and infectious disease treatment, along with Noninvasive Prenatal Testing, transplant medicine, and pharmacogenomics. Targeted gene panels and gene expression profiling through qPCR remain the two most common applications for NGS sequencers in a pathology laboratory. While oncology remains a primary area of NGS use in clinics, pathologists are expected to adopt it in other areas too over the coming years. Such factors are expected to boost market growth in the forecast period.

On the other hand, the introduction of novel products is expected to boost targeted sequencing and resequencing market growth. For instance, in October 2022, the Illumina genomics Forum introduced the NovaSeq X, which can run around 20,000 whole genomes a year on one system. This novel system has 10 billion flow cells. When run at 2×150 base pair reads, it will output 6 TB. Moreover, in December 2021, F. Hoffmann-La Roche AG launched the AVENIO Edge System for simplifying the automation of NGS sample preparation and driving advancements in precision medicine. This novel system is a pre-analytical platform that offers end-to-end, integrated, consistently high-quality outcomes.

Key entities in the targeted sequencing & resequencing market are focusing on collaboration to strengthen their market position. For instance, in March 2021, Illumina collaborated with Geneseeq to commercialize and develop IVD NGS kits in China for cancer care. This novel kit was developed by using Illumina's NextSeq 550Dx sequencing system, which was approved by China's NMPA (National Medical Products Administration). Moreover, in March 2021, Hackensack Meridian Health and Genomic Testing Cooperative (GTC) entered into a partnership to establish an oncology-focused RNA and DNA sequencing laboratory in the U.S. This lab-Anthology Diagnostics-will perform NGS of cell-free DNA from liquid biopsy samples and DNA/RNA from tumor samples.

Targeted Sequencing And Resequencing Market Report Highlights:

  • The growth of the overall targeted sequencing and resequencing market is attributed to the increase in the adoption of NGS for various applications including disease diagnosis, drug development, and research applications
  • By sequencing technology, sequencing segment dominated the market owing to the increase in applications of genome sequencing in human genetic research, microbial research, cancer research, and others
  • Clinical application segment held a major share in 2022. Targeted sequencing has broadly applied in clinical research and trials for patient categorization and the development of targeted therapeutics
  • Drug development segment is expected to show significant market share in the coming years. NGS technology can develop multiple levels of genomic data needed for the drug development process from genetic modification, to transcriptome quantification and profiling, and epigenetic modifications, among others
  • By end-use, Hospitals and clinics is expected show a significant market share in the forecast period. This is attributed to the increasing usage of NGS bu clinicians to test several genes for mutations, copy number changes, and fusions
  • North America dominated the targeted sequencing and resequencing market in 2022 due to the presence of key players and favorable government initiatives from the government for increased adoption of NGS technologies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Cost-saving advantages pertaining to the adoption of targeted sequencing approach as well as reducing sequencing cost
    • 3.4.2. Advantages associated with targeted gene panels and amplicon sequencing
    • 3.4.3. Technological advancements in sequencing technology and related ancillary protocols
    • 3.4.4. Advancements to perform sequencing in less time
    • 3.4.5. Introduction of digital next-generation sequencing technology
    • 3.4.6. Rising number of targeted sequencing-based research projects and consequent popularity growth of genomic medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Challenges in handling & managing sequencing technologies in developing countries
    • 3.5.2. High cost associated with installation & maintenance of sequencing facility
    • 3.5.3. Lack of skilled & trained personnel
    • 3.5.4. Limited access to tools for genomic data manipulation and analysis
  • 3.6. Penetration and Growth Prospect Mapping 2022
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Targeted Sequencing and Resequencing Market: Technology Movement Analysis
  • 4.2. Sequencing
    • 4.2.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 4.3. Re sequencing
    • 4.3.1. Re sequencing market, 2018 - 2030 (USD Million)
      • 4.3.1.1. Electrophoresis-based sequencing
      • 4.3.1.1.1. Electrophoresis-based sequencing market, 2018 - 2030 (USD Million)
      • 4.3.1.2. NGS
      • 4.3.1.2.1. NGS market, 2018 - 2030 (USD Million)
      • 4.3.1.3. Array-based sequencing
      • 4.3.1.3.1. Array-based sequencing market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Targeted Sequencing and Resequencing Market: Application Movement Analysis
  • 5.2. Clinical applications
    • 5.2.1. Clinical applications market, 2018 - 2030 (USD Million)
  • 5.3. Plant and animal sciences
    • 5.3.1. Plant and animal sciences market, 2018 - 2030 (USD Million)
  • 5.4. Drug development
    • 5.4.1. Drug development market, 2018 - 2030 (USD Million)

Chapter 6. Type Business Analysis

  • 6.1. Targeted Sequencing and Resequencing Market: Type Movement Analysis
  • 6.2. DNA-based targeted sequencing
    • 6.2.1. DNA-based targeted sequencing market, 2018 - 2030 (USD Million)
  • 6.3. RNA-based targeted sequencing
    • 6.3.1. RNA-based targeted sequencing market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. Targeted Sequencing and Resequencing Market: End-use Movement Analysis
  • 7.2. Hospitals and clinics
    • 7.2.1. Hospitals and clinics market, 2018 - 2030 (USD Million)
  • 7.3. Academic research
    • 7.3.1. Academic research market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Targeted Sequencing and Resequencing Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD MILLION)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.4. U.K.
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. UK Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. France Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Italy Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Spain Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Denmark Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Sweden Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Reimbursement Scenario
      • 8.3.10.6. Norway Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
      • 8.4.1.1. Asia Pacific Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. South Korea Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. Australia Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Thailand Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Brazil Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Mexico Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.5.5. Argentina
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Reimbursement Scenario
      • 8.5.5.6. Argentina Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. South Africa Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. Saudi Arabia Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. UAE Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Reimbursement Scenario
      • 8.6.6.6. Kuwait Targeted Sequencing and Resequencing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant's overview
  • 9.2. Financial performance
  • 9.3. Participant categorization
    • 9.3.1. Market Leaders
    • 9.3.2. Targeted Sequencing and Resequencing Market Share Analysis, 2022
    • 9.3.3. Company Profiles
      • 9.3.3.1. Illumina, Inc.
      • 9.3.3.2. F. Hoffmann-La Roche Ltd
      • 9.3.3.3. Agilent Technologies
      • 9.3.3.4. GATC Biotech Ag
      • 9.3.3.5. Oxford Nanopore Technologies
      • 9.3.3.6. Thermo Fisher Scientific, Inc.
      • 9.3.3.7. DNASTAR Inc.
      • 9.3.3.8. QIAGEN
      • 9.3.3.9. BGI
      • 9.3.3.10. Perkin Elmer, Inc.
      • 9.3.3.11. PacBio
      • 9.3.3.12. Bio-Rad Laboratories, Inc.
      • 9.3.3.13. Integrated DNA Technologies, Inc.
      • 9.3.3.14. RainDance Technologies, Inc.
      • 9.3.3.15. PierianDx
      • 9.3.3.16. Genomatix GmbH
      • 9.3.3.17. Macrogen, Inc.
    • 9.3.4. Strategy Mapping
      • 9.3.4.1. Expansion
      • 9.3.4.2. Acquisition
      • 9.3.4.3. Collaborations
      • 9.3.4.4. Product/Service Launch
      • 9.3.4.5. Partnerships
      • 9.3.4.6. Others

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 7 Global Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Global Targeted sequencing and resequencing market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America Targeted sequencing and resequencing market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 North America Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 13 North America Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 17 U.S. Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 20 Canada Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Canada Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Europe Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 23 Europe Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Europe Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 25 Europe Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Europe Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Germany Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 30 Germany Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 U.K. Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 33 U.K. Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 34 U.K. Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 France Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 France Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 37 France Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 38 France Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Italy Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Italy Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Spain Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Spain Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Spain Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 46 Spain Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Denmark Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Denmark Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 50 Denmark Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Sweden Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Sweden Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Sweden Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Norway Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Norway Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 57 Norway Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Norway Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 China Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 65 China Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 66 China Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 67 China Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Japan Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Japan Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Japan Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 71 Japan Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 India Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 73 India Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 74 India Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 75 India Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Australia Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Australia Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Australia Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 79 Australia Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Korea Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Korea Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Korea Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 Thailand Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 86 Thailand Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 87 Thailand Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Latin America Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 89 Latin America Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Latin America Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 91 Latin America Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 92 Latin America Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Brazil Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 94 Brazil Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 96 Brazil Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 97 Mexico Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Mexico Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 99 Mexico Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 100 Mexico Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 Argentina Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 102 Argentina Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 104 Argentina Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Targeted sequencing and resequencing market, by Country, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 109 Middle East & Africa Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 110 South Africa Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 111 South Africa Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 113 South Africa Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 UAE Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 119 UAE Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 120 UAE Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 121 UAE Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Targeted sequencing and resequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Targeted sequencing and resequencing market, by application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Targeted sequencing and resequencing market, by type, 2018 - 2030 (USD Million)
  • Table 125 Kuwait Targeted sequencing and resequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Targeted Sequencing And Resequencing, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global Targeted Sequencing And Resequencing Market: Technology Movement Analysis
  • Fig. 17 Global Targeted Sequencing And Resequencing Market, for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 18 Global Targeted Sequencing And Resequencing Market, for Re sequencing, 2018 - 2030 (USD Million)
  • Fig. 19 Targeted Sequencing And Resequencing Market, for Electrophoresis-based resequencing, 2018 - 2030 (USD Million)
  • Fig. 20 Targeted Sequencing And Resequencing Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 21 Targeted Sequencing And Resequencing Market, for Array-based resequencing, 2018 - 2030 (USD Million)
  • Fig. 22 Global Targeted Sequencing And Resequencing Market, for Application, Movement Analysis
  • Fig. 23 Global Targeted Sequencing And Resequencing Market, for Clinical application, 2018 - 2030 (USD Million)
  • Fig. 24 Global Targeted Sequencing And Resequencing Market, for Plant and animal sciences,2018 - 2030 (USD Million)
  • Fig. 25 Global Targeted Sequencing And Resequencing Market, for Drug development, 2018 - 2030 (USD Million)
  • Fig. 26 Global Targeted Sequencing And Resequencing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Targeted Sequencing And Resequencing Market, for type, Movement Analysis
  • Fig. 28 Global Targeted Sequencing And Resequencing Market, for DNA-based targeted sequencing, 2018 - 2030 (USD Million)
  • Fig. 29 Global Targeted Sequencing And Resequencing Market, for RNA-based targeted sequencing, 2018 - 2030 (USD Million)
  • Fig. 30 Global Targeted Sequencing And Resequencing Market, for End-use, Movement Analysis
  • Fig. 31 Global Targeted Sequencing And Resequencing Market, for Hospitals & clinics, 2018 - 2030 (USD Million)
  • Fig. 32 Global Targeted Sequencing And Resequencing Market, for Academic research, 2018 - 2030 (USD Million)
  • Fig. 33 Global Targeted Sequencing And Resequencing Market, for Others,2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Outlook, 2022 & 2030
  • Fig. 36 Global Targeted Sequencing And Resequencing Market: Region Movement Analysis
  • Fig. 37 North America Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 42 U.K. Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Targeted Sequencing And Resequencing Market,2018 - 2030 (USD Million)
  • Fig. 47 Denmark Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Targeted Sequencing And Resequencing Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Targeted Sequencing And Resequencing Market, Ansoff Matrix
  • Fig. 64 Market differentiators
  • Fig. 65 Key company market share analysis, 2022
  • Fig. 66 Company market position analysis
  • Fig. 67 Competitive dashboard analysis
  • Fig. 68 Regional network map